yeah, with this shorting nowadays, trading apps in every kid's hands, probably Novartis or Pfizer or many other wouldn't become big pharmas but remain penny stocks:D They had luck, where offering prices for stocks haven't been dictated by crazy shorting (I exaggerated of course). On the other hand, suspend the most advanced trial was not so clever of IMUC